Experts are celebrating a breakthrough in HIV prevention. Doctors say it could mean we're one step closer to eradicating the decades-old epidemic. As CBS News New York's John Dias explains, there's ...

In 2024, HIV/AIDS deaths in Kenya were highest among the 35-44 age group, with 733 fatalities recorded. This was followed by ...

Friday, July 25, 2025 The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including NVIDIA Corp.

I’m standing at the steps of the San Francisco City Hall. It’s evening. I look up and see spotlights illuminating the Grand Dome and two flags whipping in the wind. Someone on the speaker’s stand is ...

A federal judge extended a temporary legal block that prevents Idaho from verifying the immigration status of people ...

Motorists will face higher fines for driving below the speed limit in the left lane of a Louisiana highway starting Friday.

More than 150,000 voters will be affected when Louisiana officially ends recognition of the Independent Party this Friday.

Long-acting injectable cabotegravir (Vocabria; ViiV Healthcare) and rilpivirine (Rekambys; ViiV Healthcare) (CAB+RPV) for use as antiretroviral therapy (ART) was preferred by patients in the phase ...

Jigawa State Agency for the Control of AIDS (JISACA) has targeted to eliminate HIV/AIDS by the year 2030. The agency’s manager, Ibrahim Almajiri, stated ...

The FDA has approved a breakthrough preventative treatment for HIV that could change the course of the AIDS epidemic. But deep cuts to health initiatives could hinder the rollout. Lenacapavir not ...

After the virologic failure of cabotegravir/rilpivirine and despite dual-class resistance mutations, Canadian doctors have had surprising success with a single pill ...

Global HIV gains at risk as funding crisis sparks urgent call to action Severe cuts to international aid are disrupting lifesaving HIV services in vulnerable countries, with UNAIDS warning of ...